Assessing the Efficacy of Classical and Deep Neuroimaging Biomarkers in Early Alzheimer's Disease Diagnosis (2410.24002v1)
Abstract: Alzheimer's disease (AD) is the leading cause of dementia, and its early detection is crucial for effective intervention, yet current diagnostic methods often fall short in sensitivity and specificity. This study aims to detect significant indicators of early AD by extracting and integrating various imaging biomarkers, including radiomics, hippocampal texture descriptors, cortical thickness measurements, and deep learning features. We analyze structural magnetic resonance imaging (MRI) scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohorts, utilizing comprehensive image analysis and machine learning techniques. Our results show that combining multiple biomarkers significantly improves detection accuracy. Radiomics and texture features emerged as the most effective predictors for early AD, achieving AUCs of 0.88 and 0.72 for AD and MCI detection, respectively. Although deep learning features proved to be less effective than traditional approaches, incorporating age with other biomarkers notably enhanced MCI detection performance. Additionally, our findings emphasize the continued importance of classical imaging biomarkers in the face of modern deep-learning approaches, providing a robust framework for early AD diagnosis.
- The estimation of the global prevalence of dementia from 1990-2019 and forecasted prevalence through 2050: an analysis for the global burden of disease (GBD) study 2019. Alzheimer’s & Dementia, 17:e051496, 2021.
- Alzheimer’s disease. The Lancet, 388(10043):505–517, 2016.
- Early detection of Alzheimer’s disease using MRI hippocampal texture. Human Brain Mapping, 37(3):1148–1161, 2016.
- Volumetric MRI measurements can differentiate Alzheimer’s disease, mild cognitive impairment, and normal aging. International Psychogeriatrics, 14(1):59–72, 2002.
- Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain, 132(8):2036–2047, 2009.
- NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s & Dementia, 14(4):535–562, 2018.
- Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer’s disease cohorts. Frontiers in Aging Neuroscience, 16:1345417, 2024.
- Deep learning in medical image analysis. Annual Review of Biomedical Engineering, 19(1):221–248, 2017.
- Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimer’s & Dementia, 9(3):332–337, 2013.
- Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3):341–355, 2002.
- FAST-AID Brain: Fast and accurate segmentation tool using artificial intelligence developed for brain. arXiv preprint arXiv:2208.14360, 2022.
- Heterogeneous learning for brain lesion segmentation, detection, and classification. In Northern Lights Deep Learning Conference 2024, 2024.
- GAN-ISI: Generative adversarial networks image source identification using texture analysis. In CLEF (Working Notes), pages 1588–1595, 2023.
- Measurement of cortical thickness from MRI by minimum line integrals on soft-classified tissue. Human Brain Mapping, 30(10):3188–3199, 2009.
- A closer look at spatiotemporal convolutions for action recognition. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, pages 6450–6459, 2018.
- Med3D: Transfer learning for 3D medical image analysis. arXiv preprint arXiv:1904.00625, 2019.
- Non-reference quality assessment for medical imaging: Application to synthetic brain MRIs. arXiv preprint arXiv:2407.14994, 2024.
- Xgboost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pages 785–794, 2016.